Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2020
Reporting Period: Second quarter ended June 30, 2020
This filing serves as a notification that the Company issued a press release on August 6, 2020, announcing its financial results for the second quarter of 2020. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes regarding financial performance or operations are detailed in this specific text. The document solely confirms the issuance of the Q2 2020 results announcement.
Guidance, Outlook, and Risks
This filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items, if present, would be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2020) for actual Q2 2020 financial figures.
- Verify the Company's liquidity position and cash burn rate in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if the Company provided updated full-year guidance in the referenced announcement.